Greenland Capital Management »

Alnylam Pharmaceuticals shares owned by Greenland Capital Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Greenland Capital Management from 13F filings

Historical chart of Greenland Capital Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Greenland Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Greenland Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $893k 2.0k 456.00
2025-06-30 $326k 1.0k 326.09
2025-03-31 $270k 1.0k 270.02
2024-12-31 $471k 2.0k 235.31
2024-09-30 $304k 1.1k 275.03

More positions owned by Greenland Capital Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation Call Option (MSFT)
Wec Energy Group (WEC)
Visa Com Cl A Call Option (V)
Coreweave Com Cl A Put Option (CRWV)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
RIGETTI COMPutING *w Exp 03/02/202 (RGTIW)
Alliant Energy Corporation (LNT)
CMS Energy Corporation (CMS)
Kellogg Company Put Option (K)
Wp Carey (WPC)
Duke Energy Corp Com New (DUK)
Essential Utils (WTRG)
Amazon Call Option (AMZN)

View all positions for Greenland Capital Management

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals